Mesenchymal Stem Cell Therapy Modulates the Inflammatory Response in Experimental Traumatic Brain Injury
Therapy with mesenchymal stem cells (MSCs) has showed to be promising due to its immunomodulatory function. Traumatic brain injury (TBI) triggers immune response and release of inflammatory mediators, mainly cytokines, by glial cells creating a hostile microenvironment for endogenous neural stem cel...
Saved in:
| Main Authors: | Layla T. Galindo, Thais R. M. Filippo, Patricia Semedo, Carolina B. Ariza, Caroline M. Moreira, Niels O. S. Camara, Marimelia A. Porcionatto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Neurology Research International |
| Online Access: | http://dx.doi.org/10.1155/2011/564089 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The changes of digestive system inflammatory, oxidative stress, and histopathology factors following oral mesenchymal stem cells administration in rats with traumatic brain injury
by: Masoud Eslami, et al.
Published: (2025-03-01) -
Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond
by: Aref Yarahmadi, et al.
Published: (2025-02-01) -
Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects
by: Ming-wei Liu, et al.
Published: (2025-04-01) -
Unraveling the influence of astrocytes on endothelial cell transcription: Towards understanding blood-brain barrier in vitro models’ dynamics
by: Laura Nicoleti Zamproni, et al.
Published: (2025-05-01) -
New insights into mesenchymal stem cells in inflammatory subtypes of asthma
by: Zheng-yan Hou, et al.
Published: (2025-08-01)